Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 4, 2006, Pages 381-387

  Ohata, Shuzo ^a   Ishibashi, Yutaka ^a   Shimada, Toshio ^a   Takahashi, Nobuyuki ^a   Sugamori, Takashi ^a   Sakane, Takeshi ^a   Hirano, Yoshifumi ^a   Oyake, Nobuyuki ^a   Murakami, Yo ^a   Higami, Tetsuya ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

8 iso prostaglandin F2 ; Beraprost sodium; Prostaglandin I2; Reactive hyperemia

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BERAPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIARRHEA; DRUG EFFECT; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPEREMIA; MALE; OXIDATIVE STRESS; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; CORONARY ARTERIOSCLEROSIS; DINOPROST; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; FOREARM; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; MALE; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 33645077867     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04379.x     Document Type: Article

References (39)

1. Moncada S Gryglewski R Bunting S Vane J An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 1976 263 663 5
2. Armstrong J Lattimer N Moncada S Vane J Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits BrJPharmacol 1978 62 125 30
3. Moncada S Biological importance of prostacyclin BrJPharmacol 1982 76 3 31
4. Nagaya N Uematsu M Okano Y et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension JAmColl Cardiol 1999 34 1188 92
5. Okano Y Yoshioka T Shimouchi A Satoh T Kunieda T Orally active prostacyclin analogue in primary pulmonary hypertension Lancet 1997 349 1365
6. Ono F Nagaya N Okumura H et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction Chest 2003 123 1583 8
7. Lievre M Morand S Besse B Fiessinger JN Boissel JP Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: A double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group Circulation 2000 102 426 31
8. Mohler ERr Hiatt WR Olin JW Wade M Jeffs R Hirsch AT Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: A double-blinded, randomized, controlled trial JAmColl Cardiol 2003 41 1679 86
9. Matsumoto K Morishita R Tomita N et al. Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue JEndocrinol 2002 175 217 23
10. Sakai A Yajima M Nishio S Cytoprotective effect of TRK-100, a prostacyclin analogue, against chemical injuries in cultured human vascular endothelial cells Life Sci 1990 47 711 19
11. Ishibashi Y Shimada T Sakane T et al. Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure JAmColl Cardiol 2000 36 1605 11
12. Sakane T Ishibashi Y Shimada T et al. Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: Role of endothelium-derived nitric oxide JCardiovascPharmacol 2000 36 188 95
13. Ohata S Ishibashi Y Hirano Y et al. Relationship between endothelial function and female hormone level in very old females: Evaluation from ischemic reactive hyperemic response in forearm vessels JCardiol 2000 35 417 24
14. Anderson J Meredith T Charbonneau F et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans Circulation 1996 93 1647 50
15. Tamai O Matsuoka H Itabe H Wada Y Kohno K Imaizumi T Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 1997 95 76 82
16. Kansui Y Fujii K Goto K Abe I Iida M Effects of fluvastatin on endothelium-derived hyperpolarizing factor- and nitric oxide-mediated relaxations in arteries of hypertensive rats ClinExpPharmacolPhysiol 2004 31 354 9
17. Mancini B Henry C Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 1996 94 258 65
18. Resende AC Pimentel AM de Moura RS Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats ClinExpPharmacolPhysiol 2004 31 756 61
19. Clarkson P Adams R Powe J et al. Oral l -arginine improves endothelium-dependent dilation in hypercholesterolemic young adults JClinInvest 1996 97 1989 94
20. Levine G Frei B Koulouris S Gerhard M Keaney JJ Vita J Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 1996 93 1107 13
21. Nishimura M Nozaki O Nakano H Tsuchida H Yamada K The effect of PGI2 analogue on vascular endothelial function and platelet aggregation in patients with NIDDM JDiabetes Complications 1995 9 330 3
22. Tomiyama H Arai T Hirose K et al. Effects of acute administration of beraprost sodium on parameters related to atherosclerotic vascular damage in coronary artery disease JCardiol 2004 43 53 8
23. Sinzinger H Feigl W Silberbauer K Prostacyclin generation in atherosclerotic arteries Lanset 1979 2 469
24. Czervionke R Smith J Fry G Hoak J Haycraft D Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence JClinInvest 1979 63 1089 92
25. Eldor A Falcone D Hajjar D Minick C Weksler B Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells JClinInvest 1981 67 735 41
26. Ohno K Nagase H Matsumoto K Nishiyama H Nishio S Stereoselective synthesis of 5,6,7-trinor-4,8-inter-m-phenylene-PGI2 derivatives and their inhibitory activities to human platelet aggregation AdvProstaglandin Thromboxane Leukot Res 1985 15 279 81
27. Akiba T Miyazaki M Toda N Vasodilator actions of TRK-100, a new prostaglandin I2 analogue BrJPharmacol 1986 89 703 11
28. Kainoh M Maruyama I Nishio S Nakadate T Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level BiochemPharmacol 1991 41 1135 40
29. Ollivier V Parry G Cobb R de Prost D Mackman N Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells JBiolChem 1996 271 20 28 35
30. Goya K Otsuki M Xu X Kasayama S Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus Metabolism 2003 52 192 8
31. Imai-Sasaki R Kainoh M Ogawa Y Ohmori E Asai Y Nakadate T Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability Prostaglandins Leukot Essent Fatty Acids 1995 53 103 8
32. Inoue M Tsutou A Kato A Yosii T Investigation of Lipid Peroxide Values in Human Serum Determined by Hemoblobin-Methylene Blue Method and Inhibitory Effect Lipid Peroxidation JpnPharmacolTher 1995 23 121 3
33. Okuyama M Kambayashi J Sakon M Kawasaki T Monden M PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47phox phosphorylation Life Sci 1995 57 1051 9
34. Ohmori M Kitoh Y Kawaguchi A Harada K Sugimoto K Fujimura A Enhanced neutrophil superoxide anion production and its modification by beraprost sodium in spontaneously hypertensive rats AmJHypertens 2001 14 722 8
35. Niwano K Arai M Tomaru K Uchiyama T Ohyama Y Kurabayashi M Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: Close link between PGI2 signal and NO pathways CircRes 2003 93 523 30
36. Takahashi N Ishibashi Y Shimada T et al. Atrial fibrillation impairs endothelial function of forearm vessels in humans JCardFail 2001 7 45 54
37. Guerrero E Voces F Ardanaz N Montero M Arevalo M Sevilla M Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats JCardiovasc Pharmacol 2003 42 348 55
38. Wilmink HW Twickler MB Banga JD et al. Effect of statin versus fibrate on postprandial endothelial dysfunction: Role of remnant-like particles Cardiovasc Res 2001 50 577 82
39. Zhou M Adam A Jaimes E Raij L In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II Hypertension 2003 42 945 51